Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
RT201
- Development stage
- Unknown
- Lead developer
- Suzhou Ruotai Pharmaceutical Technology
- Modality
- Cell Therapies, Vaccines & Immunotherapeutics
- Administration
- Intravenous
01
Overview
RT201 is a tumor antigen-specific macrophage tumor vaccine developed as a cell therapy for the treatment of advanced malignant tumors, with a primary focus on advanced cervical carcinoma. The therapy involves screening for tumor-specific antigens, HLA typing, blood sample collection, cell separation and culture, and reinfusion of modified cells into the patient. This individualized approach aims to stimulate an immune response against cancer cells by leveraging macrophages that are specific to tumor antigens. Clinical trials are ongoing to evaluate its safety and efficacy in patients with advanced cancers[1][3][4].
- Other names
- Tumor Antigen-specific Macrophage Tumor Vaccine
02
Targets
Neoantigen (Patient-specific tumor-associated antigen peptides presented by HLA class I molecules)
Beyond the preview
Go deeper on RT201.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RT201.